Category : COVID-19 | Sub Category : Lockdown Posted on 2020-04-30 12:09:00
While the developed world will no doubt manage to claw their way out of the COVID-19 crisis, India has always been the perpetual wild card. It is here that the world has most feared the hammer will hit hardest. And yet, if we look at the numbers, however academically brutal it may sound, the story isn’t playing out as badly as we expected, so far.
India which is not a part of the first world countries was expected to be affected by coronavirus extensively, as it is the second most populated country. India is fighting efficiently against the pandemic situation, while countries like the USA and Italy are facing difficulty in managing the steep growth of the death curve.
India was the first nation to essentially shut its borders cancelling visas and denying entry to all but a few selected foreigners. Some states such as Kerala are beginning to beef up internal borders checking the temperature of passengers in the car and screening people on trains. Demographics also work to India’s advantage. The population here is considerably younger than in the countries. As from the data of WHO, it is seen that young patients have a better chance of surviving the viral attack.
The Indian government has taken the best initiative of a total countrywide lockdown from 25th March and it has been extended till 3rd May. Due to this lockdown, India has been able to control the outbreak of the virus for a huge percentage. The government has ensured the unhampered supply of essential commodities and medicines for its common people. Various funds like PM CARES and West Bengal State Emergency Relief Fund has been created which will be used for combat, containment and relief efforts against the coronavirus outbreak.
Presently it is seen that India’s malarial drug hydroxychloroquine is powering the global coronavirus war and ever-rising global demand for the antimalarial drug hydroxychloroquine. The country meets 82-85% of the medicine’s requirement worldwide and has agreed to export it to the USA and Brazil among other nations after a request from the President. Zydus Cadila and Ipca Laboratories are the biggest hydroxychloroquine manufacturers in India.
By: Soumyadeep Chattopadhyay, B.Pharm 2nd Year, 4th Semester